GSK wins regulatory boost for once-monthly liver drug efimosfermin in MASH push
The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need
The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
By cutting pain crises & boosting haemoglobin
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
Medical experts point to a growing body of research linking energy drinks to liver injury
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Subscribe To Our Newsletter & Stay Updated